Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Mead

Showing results (211-220 of 231) with videos related to

Pageof 24
Sort By:
Acta Neuropathologica|January 21, 2014
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansionsMichael D Gallagher, Eunran Suh, Murray Grossman, et al.
Brain : a Journal of Neurology|September 26, 2018
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriersMing Zhang, Raffaele Ferrari, Maria Carmela Tartaglia, et al.
Nature Genetics|September 8, 2009
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseDenise Harold, Richard Abraham, Paul Hollingworth, et al.
Journal of Alzheimer'S Disease : JAD|October 27, 2011
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's diseaseAmy Gerrish, Giancarlo Russo, Alexander Richards, et al.
The Lancet. Neurology|December 8, 2019
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort studyKatrina M Moore, Jennifer Nicholas, Murray Grossman, et al.
Molecular Neurodegeneration|December 2, 2025
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's diseaseOlav M Andersen, Matthijs W J de Waal, Giulia Monti, et al.
Nature Genetics|November 21, 2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's diseaseHenne Holstege, Marc Hulsman, Camille Charbonnier, et al.
Acta Neuropathologica|February 11, 2019
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDCyril Pottier, Yingxue Ren, Ralph B Perkerson, et al.
Nature Communications|April 25, 2025
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome SequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
Pageof 24

Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Acta Neuropathologica|January 21, 2014
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansionsMichael D Gallagher, Eunran Suh, Murray Grossman, et al.
Brain : a Journal of Neurology|September 26, 2018
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriersMing Zhang, Raffaele Ferrari, Maria Carmela Tartaglia, et al.
Nature Genetics|September 8, 2009
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseDenise Harold, Richard Abraham, Paul Hollingworth, et al.
Journal of Alzheimer'S Disease : JAD|October 27, 2011
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's diseaseAmy Gerrish, Giancarlo Russo, Alexander Richards, et al.
The Lancet. Neurology|December 8, 2019
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort studyKatrina M Moore, Jennifer Nicholas, Murray Grossman, et al.
Molecular Neurodegeneration|December 2, 2025
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's diseaseOlav M Andersen, Matthijs W J de Waal, Giulia Monti, et al.
Nature Genetics|November 21, 2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's diseaseHenne Holstege, Marc Hulsman, Camille Charbonnier, et al.
Acta Neuropathologica|February 11, 2019
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDCyril Pottier, Yingxue Ren, Ralph B Perkerson, et al.
Nature Communications|April 25, 2025
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome SequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
Pageof 24